Vivek Wadhwa
entrepreneurMale0.0Global Dominance: 0.00%
Vivek Wadhwa is the CEO of Vionix Biosciences and a former distinguished fellow at Harvard Law School and Carnegie Mellon. He has been vocal about the detrimental effects of Trump's $100,000 H-1B visa fee, arguing that it could drive skilled Indian professionals back to India, ultimately benefiting the Indian economy.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Vivek Wadhwa describes the situation as 'a Trump taco, noise that scared everyone.'
H-1B fears cool, companies hiring from US campuses to gainThe Times of India·
India· 2025-10-22
India· 2025-10-22
Vivek Wadhwa warned that Trump’s $100,000 H-1B fee is economic suicide for America.
Techies’ ‘ghar wapsi’ will be boon for offshoring: Experts after $100k fees imposed on H1-B visaThe Times of India·India· 2025-09-21
India· 2025-09-21
